At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Nov 6, 2026 at 16:05 ET
Two insiders at Vericel sold shares totaling $892K in open-market transactions following the company's strong Q3 2026 earnings beat and raised guidance. The sales were conducted under 10b5-1 plans, and the total value represents 0.04% of market cap, which is trivial relative to the company's $2.3B valuation.
- Two insiders sold shares: Director Zerbe sold 2.5K shares ($114K) and CLO Flynn sold 15K shares ($779K), both under 10b5-1 plans.
- Total open-market sales: $892K, representing 0.04% of $2.3B market cap.
- Sales occurred one day after Vericel reported Q3 revenue of $85.4M (+26% YoY), beating consensus of $78.0M, and GAAP EPS of $0.27 vs $0.06 consensus.
- Company raised full-year revenue guidance to $344M-$346M and adjusted EBITDA margin guidance to 28%.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access